Enhancement of Silymarin Anti-Fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) Β-Cyclodextrins in a Mouse Model of Liver Fibrosis
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00883
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 13, 2018
Authors
Publisher
Frontiers Media SA